Our Firm hears from consumers on a regular basis who allegedly suffered liver damage serious enough to result in hospitalization, liver transplantation, and even death, following use of a Tylenol product.
New York, New York (PRWEB) January 19, 2014
Tylenol lawsuits (http://www.tylenollawsuitcenter.com/) continue to mount in the federal multidistrict litigation now underway in U.S. District Court, Eastern District of Pennsylvania, Bernstein Liebhard LLP reports. According to an updated case list issued by the U.S. Judicial Panel on Multidistrict Litigation (JPML) on January 15, 2014, at least 120 claims have been filed in the proceeding. All of the lawsuits pending in the litigation allege that use of Tylenol-brand medications caused patients to suffer serious liver damage, even when used according to label directions. (In Re: Tylenol (Acetaminophen) Marketing, Sales Practices and Products Liability Litigation, MDL No. 2436)
“Our Firm hears from consumers on a regular basis who allegedly suffered liver damage serious enough to result in hospitalization, liver transplantation, and even death, following use of a Tylenol product. We are not surprised to see that this litigation is growing at such a fast rate,” says Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is offering free Tylenol lawsuit reviews to victims of severe liver damage allegedly associated with the use of Tylenol-brand medications.
Tylenol and Liver Damage Allegations
According to court documents, the JPML established the Tylenol litigation in the Eastern District of Pennsylvania in April 2013. At that time, only 27 product liability claims involving liver injury allegations were pending in federal courts around the country. All of the Tylenol lawsuits filed in the proceeding accuse Johnson & Johnson and its McNeil Consumer Healthcare unit of failing to provide consumers with adequate warnings regarding the association between the acetaminophen in Tylenol and liver damage.
In 2009, the U.S. Food & Drug Administration (FDA) reported that acetaminophen, the active ingredient in Tylenol-brand over-the-counter medications, was the leading cause of acute liver failure in the U.S. between 1998 and 2003.* Most recently, the FDA limited the amount of acetaminophen in prescription medications to 325 mg per tablet. According to a notice posted on the Federal Register, the new limits went into affect this month.
Alleged victims of acetaminophen-induced liver damage that may be related to the use of Tylenol-brand medications could be entitled to compensation for their injury-related damages. To learn more about filing a Tylenol lawsuit, please visit Bernstein Liebhard LLP’s website, or call 800-511-5092 to arrange for a free legal review.
*fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/Drugs/DrugSafetyandRiskManagementAdvisoryCommittee/UCM164897.pdf, FDA, 2009
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 11 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP